Heterocyclic antiviral compounds

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01) A61K 31/5025 (2006.01) A61P 31/12 (2006.01) A61P 31/18 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2709348

Compounds of formula (I), wherein R1, R2, R3, X1, X2 and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-I reverse transcriptase and afford a method for prevention and treatment of HIV-I infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula (I) useful for the prevention and treatment of HIV-I infections and the treatment of AIDS and/or ARC.

La présente invention concerne des composés de formule (I), dans laquelle R1, R2, R3, X1, X2 et Ar, sont tels que définis dans le présent document ou des sels pharmaceutiquement acceptables de ceux-ci, qui inhibent la transcriptase inverse du VIH I et permettent un procédé de prévention et de traitement des infections dues au VIH I et de traitement du SIDA et/ou du syndrome pré-SIDA. La présente invention concerne également des compositions contenant des composés de formule (I) utiles pour la prévention et le traitement des infections dues au VIH I et pour le traitement du SIDA et/ou du syndrome pré-SIDA.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic antiviral compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic antiviral compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic antiviral compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1739096

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.